Bristol Myers Squibb Receives Positive CHMP Opinion for Onureg® as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia in First Remission Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma Biotech Investing
BioHarvest Sciences Invites You to Join Us at the Benzinga Cleantech Small Cap Conference Biotech Investing
AbbVie Receives Health Canada Approval of HUMIRA® for the Treatment of Pediatric Patients with Moderately to Severely Active Ulcerative Colitis Biotech Investing
BLU NOTICE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against BELLUS Health, Inc.- BLU Biotech Investing
BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com Biotech Investing
Wellteq Digital Health Inc. to Present at the Planet Microcap Showcase: Virtual on Thursday, April 22, 2021 Biotech Investing
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
